Table 1. Demographic and visual clinical characteristics of patients with pseudoexfoliative glaucoma (PEG), patients with pseudoexfoliation syndrome (PEX), and the controls.

(1)

Table 1. Demographic and visual clinical characteristics of patients with pseudoexfoliative glaucoma (PEG), patients with pseudoexfoliation syndrome (PEX), and the controls.

PEG (n=214)

PEX (n=214)

Control

(n=214) P

Age (years), mean ± SD median (Q1-Q3)

71.1 ± 7.7 72 (66.0-77.0)

69.7 ± 6.7 69 (65.0-74.0)

70.0 ± 7.9

69 (65.0-75.0) 0.069^a Gender

male/female, n male/female, %

128/86 59.8/40.2

114/100 53.3/46.7

100/114 46.7/53.3

0.025^a 0.007^b 0.176^c 0.172^d

Systemic hypertension, n (%) 106 (49.5) 105 (49.1) 102 (47.7) 0.922^a

Diabetes, n (%) 53 (24.8) 61 (28.5) 56 (26.2) 0.676^a

Cardiovascular disease, n (%) 58 (27.1) 66 (30.8) 64 (29.9) 0.676^a

Smokers, n (%) 33 (15.4) 32 (15.0) 38 (17.8) 0.699^a

Intraocular pressure (IOP, mmHg), mean ± SD median (Q1-Q3)

21.5 ± 4.8 21.0 (18.0 – 24.0)

20.1 ± 5.5 19.0 (16.0 – 23.0)

19.7 ± 5.5

18.5 (16.0 – 23.0) 0.000 Visual Field Score (VFS), mean ± SD

median (Q1-Q3)

2.61 ± 0.81 2.00 (2.00 – 3.00)

1.00 ± 0.00 1.00 (1.00 – 1.00)

1.00 ± 0.00

1.00 (1.00 – 1.00) 0.000 Mean deviation (MD), mean ± SD

median (Q1-Q3)

-6.54 ± 5.86 -3.75 (-7.60 – -2.80)

-0.97 ± 0.56 -0.80 (-1.50 – -0.50)

-0.95 ± 0.57

-0.80 (-1.40 – -0.48) 0.000 Pattern standard deviation (PSD), mean ± SD

median (Q1- Q3)

4.89 ± 2.98 3.80 (2.80 – 6.10)

1.45 ± 0.23 1.40 (1.30 – 1.60)

1.45 ± 0.24

1.40 (1.20 – 1.63) 0.000 Data which were expressed as mean +± SD in the first row, and median (Q1-Q3 quartiles) in the second row were compared using the Kruskal-Wallis test

Data which were expressed as frequencies and percentages were compared using the Pearson ²test. ^a Comparison of PEG, PEX and control group, ^b PEG vs. control, ^cPEX vs. control, ^d PEG vs. PEX

(2)